Treasure Chests and Capital Raises

….well in a rather desperate attempt to give us punters something to chat about  rather than eating each other alive or at least directing perfectly warranted vitriol against previous management, here's a TC and CR's post.

Here's the Treasure Chest complete with highlighting which, albeit somewhat on the piss, defines what I think are the conversation points.

Two late stage formulation development and stiffymist. What's up with stiffymist anyway, I thought that the bioequivalence was demonstrated by the NVDL clinical studies but was the IND or has that been progressed by SUDA.




And of course there is the imminent CR.

I'm starting to think that maybe Bealo was right and that it may not be the current quarter for the CR it could very well be the next - it's still coming.

There are two reasons for it's imminence. First and most importantly is that we haven't got any money which is probably enough.

The other is that Hopper ain't here for a haircut, he's here to develop anagrelide, that's his goal and I expect the rest of the SUD stable is a means to an end for him and pretty much Baker's job to sort out. He wants the proof of concept study to occur so that the real development of this potential cancer treatment can be added to the physicians tool kit. By the way if PoC is successful that instantly values this product (probably not at 0.5 billion) but certainly multiples of the current mkt Cap.

So the only question is does a nugget (as compared to blind mullet) get dug up first or does the CR.